Optomed Oyj (HEL:OPTOMED)
1.748
-0.010 (-0.57%)
Aug 12, 2026, 6:29 PM EET
Optomed Oyj Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.75 | 9.91 | 10.47 | 7.12 | 8.52 | 6.8 |
Cash & Short-Term Investments | 7.75 | 9.91 | 10.47 | 7.12 | 8.52 | 6.8 |
Cash Growth | -19.98% | -5.33% | 47.05% | -16.50% | 25.28% | - |
Accounts Receivable | 3.35 | 2.76 | 2.41 | 2.58 | 4.57 | 4.63 |
Other Receivables | - | 0.72 | 0.86 | 0.61 | - | - |
Total Trade Receivables | 3.35 | 3.47 | 3.27 | 3.19 | 4.57 | 4.63 |
Inventory | 2.78 | 2.38 | 1.96 | 2.82 | 3 | 2.94 |
Total Current Assets | 13.88 | 15.77 | 15.7 | 13.13 | 16.09 | 14.37 |
Net Property, Plant & Equipment | 2.16 | 2.11 | 2.11 | 2.18 | 2.3 | 1.64 |
Other Intangible Assets | 9.68 | 9.83 | 9.71 | 9.49 | 8.64 | 8.72 |
Goodwill | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
Total Assets | 29.99 | 31.97 | 31.78 | 29.08 | 31.3 | 29 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.61 | 1.16 | 0.89 | 0.78 | 3.83 | 3.25 |
Accrued Expenses | - | 3.93 | 3.21 | 2.77 | - | - |
Current Portion of Long-Term Debt | 0.49 | 1.06 | 0.99 | 0.99 | 0.99 | 1.26 |
Current Portion of Leases | 0.43 | 0.44 | 0.5 | 0.52 | 0.41 | 0.4 |
Total Current Liabilities | 5.54 | 6.59 | 5.58 | 5.05 | 5.23 | 4.91 |
Long-Term Debt | 0.83 | 0.37 | 1.31 | 2.36 | 4.29 | 5.75 |
Long-Term Leases | 0.76 | 0.84 | 1.02 | 0.99 | 1.06 | 0.82 |
Other Long-Term Liabilities | 0.14 | 0.16 | 0.23 | 0.31 | 0.39 | 0.46 |
Total Long-Term Liabilities | 1.73 | 1.36 | 2.56 | 3.67 | 5.73 | 7.03 |
Total Liabilities | 7.27 | 7.96 | 8.14 | 8.72 | 10.96 | 11.95 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
Additional Paid-in Capital | 65.73 | 65.73 | 60.11 | 51.44 | 47.4 | 39.03 |
Accumulated Other Comprehensive Income | 0.63 | 0.86 | 0.01 | 0.33 | 0.05 | -0.09 |
Retained Earnings | -43.73 | -42.65 | -36.56 | -31.49 | -27.19 | -21.97 |
Shareholders' Equity | 22.72 | 24.02 | 23.64 | 20.36 | 20.34 | 17.05 |
Total Liabilities & Equity | 29.99 | 31.97 | 31.78 | 29.08 | 31.3 | 29 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.52 | 2.71 | 3.81 | 4.86 | 6.74 | 8.23 |
Net Cash (Debt) | 5.24 | 7.2 | 6.66 | 2.26 | 1.78 | -1.43 |
Net Cash Growth | -15.25% | 8.13% | 194.56% | 26.90% | - | - |
Net Cash Per Share | 0.26 | 0.36 | 0.36 | 0.14 | 0.12 | -0.11 |
Book Value | 22.72 | 24.02 | 23.64 | 20.36 | 20.34 | 17.05 |
Book Value Per Share | 1.15 | 1.21 | 1.27 | 1.22 | 1.39 | 1.27 |
Tangible Book Value | 8.78 | 9.93 | 9.67 | 6.62 | 7.45 | 4.08 |
Tangible Book Value Per Share | 0.44 | 0.50 | 0.52 | 0.40 | 0.51 | 0.30 |